LOX and gastric adenocarcinoma: We found that LOX expression was negatively correlated with the sensitivity of some commonly used chemotherapeutic drugs, such as fluorouracil (Figure 8A), oxaliplatin (Figure 8B), docetaxel (Figure 8C), methotrexate (Figure 8D), tegafur (Figure 8E), and paclitaxel (Figure 8F), which suggests that an enhanced drug resistance of tumor cells to multiple chemotherapeutic agents might be involved in high LOX expression-mediated poor prognosis of STAD patients.